Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach
FDA has provided input on key elements of the SER-155 allo-HSCT clinical development plans including support for the proposed primary efficacy ...
Lancashire Telegraph9h
How Eesa, 6, is inspiring others to join stem cell register
The Blackburn pupil's only chance of survival was a stem cell transplant and now the family want to inspire others to join the Anthony ...